title: Calcium Pyrophosphate Deposition Disease.
authors.affiliation: From the Division of Rheumatology, Department of Medicine, Medical College of Wisconsin (A.K.R., L.M.R.), and the Department of Medicine, Zablocki Veterans Affairs Medical Center (A.K.R.) - both in Milwaukee.
authors.forename: Ann K
authors.initials: AK
authors.lastname: Rosenthal
authors.affiliation: From the Division of Rheumatology, Department of Medicine, Medical College of Wisconsin (A.K.R., L.M.R.), and the Department of Medicine, Zablocki Veterans Affairs Medical Center (A.K.R.) - both in Milwaukee.
authors.forename: Lawrence M
authors.initials: LM
authors.lastname: Ryan
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002131:Calcium Pyrophosphate; D002356:Cartilage / Q000000981:diagnostic imaging / Q000473:pathology; D002805:Chondrocalcinosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D003460:Crystallization; D003951:Diagnostic Errors; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007269:Injections, Intra-Arterial; D008727:Methotrexate / Q000627:therapeutic use; D015995:Prevalence; D011859:Radiography; D012307:Risk Factors; D009626:Terminology as Topic
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D002131:Calcium Pyrophosphate; D008727:Methotrexate